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Abstract
Visceral leishmaniasis is a potentially fatal infectious disease caused by the protozoan parasite Leishmania infantum/chagasi
in the New World, or by L. donovani or L. infantum/chagasi in the Old World. Infection leads to a variety of outcomes ranging
from asymptomatic infection to active disease, characterized by fevers, cachexia, hepatosplenomegaly and suppressed
immune responses. We reasoned that events occurring during the initial few hours when the parasite encounters cells of
the innate and adaptive immune systems are likely to influence the eventual immune response that develops. Therefore, we
performed gene expression analysis using Affymetrix U133Plus2 microarray chips to investigate a model of early infection
with human monocyte-derived macrophages (MDMs) challenged with wild-type L. chagasi parasites, with or without
subsequent co-culture with Leishmania-naı ¨ve, autologous T-cells. Microarray data generated from total RNA were analyzed
with software from the Bioconductor Project and functional clustering and pathway analysis were performed with DAVID
and Gene Set Enrichment Analysis (GSEA), respectively. Many transcripts were down-regulated by infection in cultures
containing macrophages alone, and the pattern indicated a lack of a classically activated phenotype. By contrast, the
addition of autologous Leishmania-naı ¨ve T cells to infected macrophages resulted in a pattern of gene expression including
many markers of type 1 immune cytokine activation (IFN-c, IL-6, IL-1a, IL-1b). There was simultaneous up-regulation of a few
markers of immune modulation (IL-10 cytokine accumulation; TGF-b Signaling Pathway). We suggest that the initial
encounter between L. chagasi and cells of the innate and adaptive immune system stimulates primarily type 1 immune
cytokine responses, despite a lack of classical macrophage activation. This local microenvironment at the site of parasite
inoculation may determine the initial course of immune T-cell development.
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Introduction
Visceral leishmaniasis (VL) is a potentially fatal infectious disease
caused by the protozoan parasites Leishmania chagasi/infantum in the
Neworinpartsofthe OldWorld,orbyL.donovaniinotherregionsof
the Old World.[1] Infection leads to a variety of outcomes ranging
fromasymptomaticinfectiontoactivedisease,whichischaracterized
by fevers, cachexia, hepatosplenomegaly and suppressed immune
responses. Without treatment, most symptomatic patients die.[2]
Investigations into the mechanism underlying the immunosuppres-
sion during acute VL have demonstrated defective antigen-specific
proliferation and IFN-c responses to parasite antigen,[3–5] high
expression of IL-10 in the spleen and serum of symptomatic VL
patients[6–10] and high serum levels of IL-4, TGF-b and IL-2
receptor.[11–13] In vitro infection with Leishmania parasites
suppresses macrophage microbicidal responses and IFN-c pathway
signaling,[14–17] suggesting that these suppressive changes begin at
the earliest stages of infection. Whether this defect in macrophage
responses to Leishmania infection is communicated to local adaptive
immune cells is not known.
We reasoned that events occurring during the initial few hours
when the parasite encounters cells of the innate and adaptive
immune systems are likely to influence the eventual immune
response that develops. We hypothesized that the parasite would
cause unique changes in gene expression in both innate and
adaptive cells of the immune system encountered early in
infection. To test this hypothesis, we analyzed gene expression
with an in vitro model using human monocyte-derived macro-
phages (MDMs) challenged with L. chagasi promastigotes with or
without subsequent co-culture with Leishmania-naı ¨ve, autologous
T-cells. Gene expression analysis of RNA harvested from both
MDMs alone and the MDM-T cell co-cultures indicated a
surprising type 1 inflammatory cytokine response during the
earliest stages of parasite invasion into the host.
Materials and Methods
Parasites
A Brazilian isolate of L. chagasi (MHOM/BR/00/1669) was
maintained in hamsters by serial intracardiac injection of
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liquid hemoflagellate-modified minimal essential medium and
used within 3 weeks of isolation.[18] Parasite sub-cultures were
used on day 7 of growth for infections.
Infection protocol
On day zero, venous blood was drawn from four healthy, US
resident adult male volunteers ages 24–64 in accordance with the
human subjects guidelines approved by the University of Iowa
Institutional Review Board. None of the donors have been
exposed to Leishmania. Written consent was obtained from all
donors. Only male donors were used to eliminate, as a variable in
the analysis, the known effects of gender on VL.[2,19] PBMCs
were isolated from venous blood by density gradient sedimentation
on Ficoll-Paque Plus (GE Healthcare, Uppsala, Sweden) and
cultured in RPMI 1640 (Gibco) with 20% autologous serum in
60 ml Teflon wells (Savillex Corporation) at 37uCi n5 %C O 2.
Serum was obtained from the volunteers using BD Vacutainer
Serum Plus Blood Collection tubes (Becton Dickson). On day 6,
human MDMs were purified by adherence to tissue culture plates
(Corning) that had been pre-coated with poly-L-lysine (0.1 mg/ml;
Sigma). After 4 hours culture in RPMI 1640 with 10% heat-
inactivated fetal calf serum (Sigma), 2 mM L-glutamine, 100U/ml
penicillin and 100 mg/ml streptomycin (Gibco) [RP-10] at 37uC,
5% CO2, non-adherent lymphocytes were rinsed off. MDMs were
infected with stationary phase L. chagasi parasites at a 10:1
parasite:MDM ratio. Plates were immediately centrifuged at 60 g
for 4 minutes at 4uC to synchronize the infections. After one hour,
non-adherent parasites were rinsed off and cells were maintained
in RP-10. PBMCs were again isolated from the same donor on day
7, and CD3
+ cells were isolated by negative selection using either a
cocktail of antibody-coated beads (anti-CD14, anti-CD19, anti-
CD56; Miltenyi Biotec) or the Pan-T-Cell Isolation Kit II
(Miltenyi Biotec) according to manufacturer’s instructions. A small
aliquot was fixed and stained for flow cytometry analysis with an
anti-CD3-PE conjugated antibody (Miltenyi Biotec) to assess
enrichment. The resultant enriched population should contain a
mixed population of both Leishmania-naı ¨ve CD4
+ and CD8
+ T
cells, but should be depleted of monocytes, dendritic cells, NK cells
and NKT cells. Negative selection routinely resulted in a
population of cells that was .90–95% CD3
+ (data not shown).
Autologous T cells were added to the infected macrophage
cultures at an estimated 3:1 T cell:MDM ratio, and the plates were
again spun at 4uC and 60 g for 4 minutes.
Assessment of infection
Macrophages were removed from the wells with citric saline
[0.135M KCl, 0.015M Trisodium citrate); Fischer] for 5 minutes
at 37uC. Infection efficiency was evaluated by manually counting
$200 macrophages in cytospin preparations (Cytospin 4,
Thermo-Shandon Fisher) stained with Diff Quik (Protocol Hema
3, Fisher Scientific). Experiments in which $70% macrophages
were infected were used for RNA extraction. In the infection
replicates used for the microarray studies, we averaged a percent
infection (mean6SEM) of 79.967.2 for the infected macrophage
only replicates and a percent infection of 7667.7 for the infected
macrophage-T-cell co-culture replicates.
RNA isolation, cDNA preparation and hybridization
Total RNA was isolated using Trizol (Invitrogen) as specified in
the manufacturer’s instructions. RNA was treated with DNaseI
and further cleaned using the Qiagen RNeasy mini-kit (Qiagen,
Hilden, Germany). RNA for microarrays was harvested from
uninfected or infected macrophages and from uninfected or
infected macrophage – T-cell co-cultures at 4 hours after the
initiation of co-culture (28 hours after initiation of infection).
RNAs for validation experiments were harvested after 4 hours,
24 hours, 2 days and 3 days of co-culture. RNA quality was
assessed using the Agilent Model 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA). cRNA was generated from five mg
of total RNA by using the Affymetrix GeneChip one-cycle target
labeling kit (Affymetrix, Inc., Santa Clara, CA) according to the
manufacturer’s recommended protocols. The resultant biotiny-
lated cRNA was fragmented and hybridized to the GeneChip
Human Genome U133 Plus 2.0 Array (Affymetrix, Inc.). The
arrays were washed, stained, and scanned using the Affymetrix
Model 450 Fluidics Station and Affymetrix Model 3000 scanner
using the manufacturer’s recommended protocols by the Univer-
sity of Iowa DNA Core Facility. Each sample and microarray
underwent standard quality control evaluations for cRNA
amplification of more than 4-fold, percentage of probe sets
reliably detecting between 40 and 60 percent present call, and a
39-59 ratio of GAPDH gene less than 3.
Microarray data analysis
Raw data analysis was performed using code written in R and
software from the open-source Bioconductor Project.[20] Prelim-
inary data quality control assessments were performed with
affyQCReport. The raw fluorescence data were background
adjusted, normalized and converted to expression-level data using
gcRMA.[21,22] For each donor, the log2 gcRMA expression data
from the uninfected sample were subtracted from the log2 gcRMA
expression data from the infected sample and then these paired
data were analyzed with RankProd[23,24] using the one-class
model. Macrophage-only data were analyzed separately from the
macrophage-T cell co-culture data. Both raw and normalized data
have been deposited with ArrayExpress (http://www.ebi.ac.uk/
microarray-as/aer/?#ae-main[0]) under accession number E-
Author Summary
Visceral leishmaniasis (VL) is a potentially fatal vector-
borne infectious disease that leads to a variety of
outcomes ranging from asymptomatic infection to symp-
tomatic disease. In northeast Brazil, the etiological agent of
VL is the protozoan Leishmania chagasi/infantum.A c t i v eV L
is characterized by fevers, weight loss, hepatosplenomegaly
and eventually immune suppression. Without treatment,
most symptomatic patients die from secondary bacterial or
viral super-infection. We hypothesized that a unique
immune response to L. chagasi is initiated early during the
initial interactions between the immune system cells that
first encounter the parasite. These include macrophages and
T-cells, elements of the innate and adaptive immune
systems, respectively. We studied an in vitro model of these
interactions in which human monocyte-derived macrophag-
es were challenged with L. chagasi, and subsequently
cultured with Leishmania-naı ¨ve, autologous T cells. Using
microarray chips, we examined changes in global gene
expression induced by these early interactions. Infection did
not elicit a classical inflammatory program in macrophages.
However, co-culture of infected macrophages and autolo-
gous T cells exhibited a pattern of gene expression,
including many markers of acute inflammation or a type 1
immune response. These data suggest that early changes at
the site of parasite infection would be conducive to the
development of a protective type 1 response, followed by
modulation of this same response.
Gene Expression in Early Leishmania Infection
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each replicate by expression level and then calculates an ‘RP-
Value’ for each probe set based on the amount that a particular
probe set appears at the top or at the bottom of the ranked list.
The RP-Value for each probe set then increases if the probe set is
consistently present at the top or the bottom of the list. The
software then re-sorts all the probe sets based on RP-Value, taking
into account all pair-wise comparisons and adjusts for multiple
hypothesis testing via permutation of the replicate labels. For each
probe set, a ‘‘Percent False Positive’’ (PFP) value is calculated as an
estimate of the false discovery rate.[23,25] The cutoff for
significance was chosen to be all genes with a PFP rate of 5% or
less. These genes, adjusted by permutation for multiple hypothesis
testing, had less than a 5% chance of representing a false positive
signal of statistically significant differential expression. After
significant genes were identified, annotation and functional
clustering was performed using DAVID.[26] The raw list of
AffyIDs for each condition (MDM vs. MDM-T cell co-culture; up
vs. down regulated by infection) was submitted as a ‘‘Gene List’’ to
DAVID and then the data were analyzed using the ‘‘Functional
Annotation Clustering’’ tool using the ‘‘Highest’’ classification
stringency setting.
Pathway analysis was performed using Gene Set Enrichment
Analysis,v.2.[27] GSEA takes a list of genes and tests whether,
within that queried list of genes, there is statistically significant
enrichment or not of pre-defined groups of genes, or ‘‘gene sets.’’
Gene sets examined through GSEA include canonical metabolic
and signaling pathways, groups of genes previously identified and
validated to be up- or down-regulated when cells are given a
particular stimulus, or genes present at a similar physical location
(e.g. within a particular cytoband). This type of analysis can detect
subtle changes present in the data. For example, if several key
members of a particular signaling pathway are all up-regulated by
5% these changes may not be detected by traditional analyses,
although these changes could biologically represent a substantial
increase in the net ‘‘flux’’ of the signaling pathway. GSEA settings
were default except for 1000 permutations, ‘‘phenotype’’ permu-
tation and calculating differential expression based on the mean
expression value for each phenotype.
Real-time PCR
cDNA was generated from the cleaned up total RNA samples
using the Superscript III First Strand Synthesis System kit
(Invitrogen) using random hexamer primers and an RNaseH-
treatment step following the manufacturer’s instructions. TaqMan
real-time PCR gene expression assays were purchased from
Applied Biosystems, Inc. (ABI) and were performed according to
the manufacturer’s instructions. Data were analyzed using the
D(DCt) method.[28]
Cytokine assays
Supernatants from three independent infections, each from a
separate individual, were assayed. The supernatants were stored at
220uC before use. Cytokine levels in the supernatants were
assessed using a panel and controls samples, from Lincoplex
(Millipore, Billerica, MA), according to the manufacturer’s
instructions. Data were generated on a BioRad Bio-Plex Assay
Reader 200 (BioRad).
Statistics
RT-PCR and cytokine data were plotted as the mean of three
independent experiments. Statistical significance was assessed with
GraphPad Prism, v.5 using a 1-way ANOVA and Tukey’s
Multiple Comparison Test or a 2-way ANOVA test.
Results
To test our hypothesis that the parasite induces unique changes
in gene expression in both innate and adaptive cells of the immune
system encountered early in infection, we examined gene
expression in four parallel conditions: (a) Uninfected MDMs, (b)
Infected MDMs, (c) Uninfected MDMs co-cultured with autolo-
gous T-cells and (d) Infected MDMs co-cultured with autologous
T-cells. A box plot of the log2 ratios of the Uninfected expression
values subtracted from the Infected expression values for all probe
sets plotted separately for each donor demonstrated that although
there was slightly more variation present in the MDM-only ratios
for Donor 4, overall there did not appear to be substantial inter-
donor variation (Figure 1). Most genes did not appear to change
markedly from zero as evidenced by the narrow range of most of
the inter-quartile boxes. Although the analyses presented below
were generated employing all 4 donors’ data, the analyses were
also tested leaving donor 4 out and did not differ substantially
(data not shown). To generate the RNA samples, we only used
infections where there was .70% infected macrophages at the
4 hour co-culture time point (MDM: 79.967.2% infection;
MDM-T-cell: 7667.7;see Methods). For subsequent experiments
over longer time intervals, the percent of infected cells stayed
roughly constant over the time intervals measured (see figure
legends).
Data generated from the analysis of RNA from cultured MDMs
alone were analyzed separately by RankProd from the data from
MDM-T cell co-cultures. The numbers and identity of genes
either up-regulated or down-regulated in infected samples
compared to uninfected samples that had a particular estimated
PFP were computed. In both culture conditions, statistically
significant differentially-regulated genes were considered if genes
met a 5% PFP cutoff. Out of 54,675 total probe sets, in the MDM
only condition RankProd identified 9 probe sets with a PFP cutoff
of #5% that were up-regulated by infection with L. chagasi and 72
probe sets that were down-regulated. In the MDM-T cell co-
culture condition, RankProd identified 116 probe sets with a PFP
cutoff of # 5% that were up-regulated by infection with L. chagasi
and 19 down-regulated probe sets. A complete list of all probe sets
identified by RankProd is provided in Table S2.
After identification of the differentially expressed probe-sets
using RankProd, the lists of AffyIDs for the up- and down-
regulated probe-sets were submitted to the DAVID bioinformatics
website to functionally cluster the various probe-sets by Gene
Ontology categories and other functional annotation.[26] Tables 1
and 2 show a selected list of the identified differentially expressed
genes grouped by functional annotation. In the MDM cultures
(Table 1), infection led to many more down-modulated than up-
regulated transcripts. In contrast to macrophage infection with
bacterial pathogens,[29] Leishmania infection of MDMs did not
lead to up-regulation of transcripts encoding proteins character-
istic of classical inflammation. Infection with L. chagasi down-
modulated several transcripts encoding proteins involved in
cellular regulation. Down-modulated gene transcripts included
those corresponding to YAF2, which encodes a protein that binds
the transcription factor YY1, eIF2C3, an initiation factor belonging
to the PIWI family that is essential for mammalian cell siRNA-
mediated gene silencing,[30] Cdc42, whose protein product is
involved in actin regulation, a guanine nucleotide exchange factor,
and a gene involved in autophagy. There was also significant
down-modulation of transcripts encoding classical inflammatory
receptors (IL-1R2 and CSF2),[29] and Peroxiredoxin 6, a protein
involved in redox cycling and oxidative defense.[31] Transcripts
encoding proteins associated with classical macrophage activation,
Gene Expression in Early Leishmania Infection
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CIITA,[32] were not differentially regulated.
The MDM-T cell co-culture condition provided a model of the
initial interaction between Leishmania-infected macrophages and
circulating T cells, using a mixed population of peripheral blood-
derived Leishmania-naı ¨ve T cells.[33] We chose an early time
point (4 hours of co-culture; 28 hours total infection time) to study
the gene expression initiated by this initial contact. In contrast to
our study of infected MDMs, the addition of T-cells to the co-
culture increased the proportion of genes that were differentially
regulated (Table 2). Of note, the mRNA encoding the early
activation T-cell marker CD69 was significantly induced in the co-
culture replicates, suggesting that we were able to successfully
extract mRNA from both the infected macrophages as well as the
added T cells. Among the many transcripts that were up-regulated
by co-culture were those that encoded proteins that promote acute
inflammation, including chemokines that attract neutrophils
(CXCL-2, 3) and resting T cells/NK cells (CXCL-10). The latter,
also called IP-10, promotes Th1-type immunity. Cytokines and
interleukins expressed uniquely in the infected co-culture condi-
tion included IL-1a, IL-1b, and IL-6 which are pro-inflammatory,
and IFN-c and IL-2 which are both produced by and promote the
development of a Th1-type cells. Consistently, the mRNA for
STAT1, a key signaling molecule in the IFN-c pathway, also
increased. Transcripts encoding other chemokines (CCL-8, 20;
CXCL-9, 11) were also induced in the co-culture. As such, the
‘‘flavor’’ of transcripts induced uniquely in co-cultures with the
addition of T-cells to infected MDMs reflects an environment
favorable for the development of type 1 immune cytokine
responses.
Similar to the results in the MDM-only condition, transcripts for
several isoforms of the MT-1 gene were highly up-regulated in co-
cultures containing infected MDMs. Due to their up-regulation
either with or without T-cells present, we presume these most
likely reflect changes in MT gene expression occurring in the
infected MDMs, although it is possible that these transcripts were
also up-regulated in the co-cultured T-cells.[34]
In order to validate some of the above data using a more
quantitative method, we performed TaqMan-based reverse
transcriptase-PCR experiments on 6 differentially regulated genes.
The relative mRNA expression levels were verified using the same
RNA samples that had been analyzed in microarrays for two
donors (Figure 2). With the exception of SNX13 which yielded
equivocal results, the direction and magnitude of calculated
change comparing infected samples to uninfected samples
corresponded to the change predicted by the microarray
expression data for both donors. SNX13 had been identified as
an up-regulated gene by microarray analysis, but did not change
appreciably above baseline by RT-PCR. In addition to the six
transcripts illustrated in Figure 2, we also validated by RT-PCR
the up-regulation of the metallothionein gene, MT1M. The
relative mRNA levels of this gene were increased roughly six-
fold after four hours of co-culture (data not shown).
In addition to the functional clustering using DAVID, we
investigated the data using the pathway software, Gene Set
Enrichment Analysis (GSEA).[27] We examined separately the
Figure 1. BoxPlot of Ratios [Infected:Uninfected] of gcRMA-transformed microarray expression data. The value of the log2(Infected
expression value 4 Uninfected expression value) for each probe set in both the MDM only condition and the MDM-T cell co-culture was calculated
and plotted separately for each donor. The central box represents the interquartile range and the solid black bar represents the median probe set.
Downstream analyses were performed using all four donor data sets.
doi:10.1371/journal.pntd.0000252.g001
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results from this analysis are represented in Table S1. When
corrected for multiple hypothesis testing (FDR q-value ,0.02[25]),
the MDM only data did not show statistically significant
enrichment of any gene sets, consistent with infected MDMs
exhibiting a ‘‘quiescent’’ phenotype. In contrast, the MDM-T cell
data demonstrated enrichment of several gene sets annotated to be
canonical immune cytokine signaling pathways as well as groups of
genes up-regulated when different cell types are stimulated with a
variety of conditions such as hypoxia, proliferation or cytokines.
Of particular interest, IL-6 related gene sets appear several times
on the list as KRETZSCHMAR_IL6_DIFF, BROCKE_IL6 and
IL6_PATHWAY. The former two gene sets include genes that are
differentially regulated when multiple myeloma cells are treated
with recombinant IL-6.[35] The IL-6 Pathway and additionally
the IL-12 Pathway gene sets (Biocarta) were both found to be
enriched within the infected MDM-T cell co-culture data set. IL-6
mRNA itself, but not IL-12 subunits, were up-regulated in co-
cultures (see Table 2). Furthermore, the GATA3 pathway
(Biocarta) and TGF-b signaling pathway (Biocarta) were also
enriched in the MDM-T-cell microarray data indicating that some
genes not belonging to inflammatory pathways were induced.
GATA3 is a transcription factor and ‘‘master regulator’’ of Th2
differentiation,[36] and TGF-b suppresses both Th1 and Th2
effector cell development.[37,38] In the primary data, IL-4
mRNA was only up-regulated 1.7-fold in contrast to IFN-c
mRNA which went up almost 3-fold. In aggregate, these data
suggest the infection induced primarily a type 1 immune cytokine
activation phenotype, but other modulatory factors (i.e. TGF-b)
may be secondarily activated.
Table 1. Modulation of MDM gene expression caused by L. chagasi infection
MDM: up-regulated transcripts (9 of 54,675 probe sets{)
Symbol Description Cytoband Fold Change % False Positive
CXCL-5 chemokine (C-X-C motif) ligand 5 4q12-q13 2.628 0.012
Metallothioneins
MT1M, F, G metallothionein 1M, 1F, 1G 16q13 2.7–21.146 0–0.05
Cell Metabolism
APOBEC-3A apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A 22q13.1-q13.2 2.578 0.013
ST3GAL3 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 1p34.1 5.267 0.015
AFF4 AF4/FMR2 family, member 4 5q31 1.851 0.015
IFI44L interferon-induced protein 44-like 1p31.1 2.094 0.049
AKR1C2 aldo-keto reductase family 1, member C2 10p15-p14 1.541 0.054
MDM: down-regulated transcripts (selected from 72 of 54,675 probe sets{)
Cell Regulation
MLL myeloid/lymphoid or mixed-lineage leukemia 11q23 0.373 0.016
YAF-2 YY1 associated factor 2 12q12 0.453 0.012
eIF2C3 translation initiation factor 2C 1p34.3 0.420 0.031
Protein Metabolism
PHGDH phosphoglycerate dehydrogenase 1p12 0.343 0.011
FMNL3 formin-like 3 12q13.12 0.394 0.014
DPEP2 dipeptidase 2 16q22.1 0.373 0.018
SENP6 SUMO1/sentrin specific peptidase 6 6q13-q14.3 0.455 0.040
Immune Response
IL1-R2 interleukin 1 receptor, type II 2q12-q22 0.200–0.425 0–0.028
TNFSF-15 tumor necrosis factor (ligand) superfamily, member 15 9q32 0.311 0.0071
SIGLEC-10 sialic acid binding Ig-like lectin 10 19q13.3 0.374 0.014
Kinase Activity
PCTK2 PCTAIRE protein kinase 2 12q23.1 0.383 0.013
PAK1 p21/Cdc42/Rac1-activated kinase 1 11q13-q14 0.396 0.015
TNFRSF-10B tumor necrosis factor receptor superfamily, member 10b 8p22-p21 0.436 0.018
Other
RAPGEF1 Rap guanine nucleotide exchange factor (GEF) 1 9q34.3 0.478 0.048
TFRC transferrin receptor (p90, CD71) 3q29 0.357 0.012
ATG16L2 ATG16 autophagy related 16-like 2 11q13.4 0.340 0.014
PRDX6 peroxiredoxin 6 1q25.1 0.398 0.017
Genes were selected from the overall list of probe sets found to be differentially regulated by RankProd with a PFP ,0.05 and functionally clustered with DAVID.
{54,675 probe sets were analyzed, and the indicated number were selected as significantly (PFP,0.05) changed between infected and noninfected macrophages.
doi:10.1371/journal.pntd.0000252.t001
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regulation, selected cytokines associated with inflammatory
responses were measured. We chose IFN-c and IL-6, whose
transcripts were up-regulated according to microarray data
(Table 2). We also examined IL-10, a cytokine that promotes
progressive VL disease, based upon the hypothesis that important
modifying factors are secondarily up-regulated in response to the
initial type 1 response.[10] The relative mRNA abundance at time
points between 4 h of co-culture (i.e. 28 hours of infection) and 3d
of co-culture were measured using TaqMan based RT-PCR gene
expression assays and normalized to GAPDH (Figure 3A, D(DCt)
method). The IFN-c mRNA peaked at 24 h at roughly three-fold
Table 2. Modulation of gene expression in MDM-T cell co-cultures induced by L. chagasi infection
MDM-T cell co-cultures: up-regulated transcripts (selected from 116 of 54,675 probe sets{)
Symbol Description Cytoband Fold Change % False Positive
CD-69 CD69 antigen 12p13-p12 1.724 0.010
Metallothioneins
MT - 1E,1F,1G, 1H,1M,1X, 2Ametallothionein genes 16q13 3.29–37.07 0 – 0
Inflammatory and Chemotactic Cytokines
IL-2 interleukin 2 4q26-q27 4.359 0
IFN-c interferon, gamma 12q14 2.966 0
CXCL-2,-3,-9,-10,-11 chemokine (C-X-C) ligands 2, 3, 9, 10 and 11 4q21, 4q21.2 1.62–2.29 0.049–0.008
CCL-8, -10 chemokine (C-C motif) ligands 8, -20 17q11.2 1.78–2.77 0
IL-6 interleukin 6 7p21 2.003 0.003
TNF-a tumor necrosis factor, alpha 6p21.3 1.487 0.039
IL-1b interleukin 1, beta 2q14 1.561 0.042
IL-1a interleukin 1, alpha 2q14 1.611 0.042
TNFSF-10, TNFSF-11 tumor necrosis factor (ligand) superfamily, members 10 and 11 3q26, 13q14 1.69, 1.85 0.022, 0.009
Inflammatory Mediators
PTGS2 prostaglandin-endoperox. synthase 2 1q25.2-q25.3 2.212 0.001
STAT1 signal transducer and activator of transcription 1 2q32.2 1.860 0.006
IFIT2, IFIT3 interferon-induced protein with tetratricopeptide repeats 2 and 3 10q23-q25 1.870; 1.786 0.008–0.010
CD-36 CD36 antigen 7q11.2 1.781 0.013
C1S complement component subunit 1s 12p13 1.721 0.017
SOD2 superoxide dismutase 2, mitochondrial 6q25.3 1.672 0.031
CSF2 colony stimulating factor 2 (granulocyte-macrophage) 5q31.1 1.639 0.034
Type 2 Transcripts
IL-4 interleukin 4 5q31.1 1.677 0.018
SOCS3 suppressor of cytokine signaling 3 17q25.3 1.653 0.025
MDM-T cell co-culture: down-regulated transcripts (selected from 19 of 54,675 probe sets{)
Symbol Description Cytoband Fold Change % False Positive
Immune Signaling
CCR-3 chemokine (C-C motif) receptor 3 3p21.3 0.427 0
IL1-R2 interleukin 1 receptor, type II 2q12-q22 0.401 0
Cell-Cycle and Amino Acid Metabolism
PSAT1 phosphoserine aminotransferase 1 9q21.2 0.470 0.003
PHGDH phosphoglycerate dehydrogenase 1p12 0.521 0.011
COL6A2 collagen, type VI, alpha 2 21q22.3 0.472 0.031
COL23A1 collagen, type XXIII, alpha 1 5q35.3 0.545 0.041
CDK-10 Cyclin-dependent kinase (CDC2-like) 16q24 0.532 0.037
GDF15 growth differentiation factor 15 19p13.1-13.2 0.542 0.039
MARS2 methionine-tRNA synthetase 2 2q33.1 0.543 0.047
Collagen subunits
COL6A2 collagen, type VI, alpha 2 21q22.3 0.472 0.031
COL23A1 collagen, type XXIII, alpha 1 5q35.3 0.545 0.041
Genes were selected from the overall list of probe sets found to be differentially regulated by RankProd with a PFP ,0.05 and functionally clustered with DAVID.
{54,675 probe sets were analyzed, and the indicated number were selected as significantly (PFP,0.05) changed between infected and noninfected macrophages.
doi:10.1371/journal.pntd.0000252.t002
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IL-6 mRNA showed a trend toward increased expression during
infection, although the changes were not statistically significant.
IL-10 mRNA did not demonstrate any significant change,
consistent with our microarray findings.
Changes in the levels of IFN-c, IL-6 and IL-10 in the
supernatants of MDM-T cell co-culture wells were measured at
the same time points (Figure 3B). In all cases, infected co-cultures
showed significant accumulation of cytokine (p,0.05) comparing
4h of co-culture to 3d of co-culture, whereas there was no similar
accumulation of cytokine in uninfected wells. IFN-c cytokine
accumulation peaked at about 4-fold above uninfected cells at
72 hours whereas IL-10 accumulated to approximately 2.5-fold
above uninfected cells. The mean percent infection levels for these
replicates were 83.262.7, 81.161.8, 71.261.3 and 63.867.3% at
4, 24, 48 and 72 hours of co-culture, respectively. Thus, despite
the fact that the levels of IFN-c increased out to 3d of co-culture,
the percent of infected cells stayed roughly constant over the same
time interval.
Discussion
Our study was designed to test the hypothesis that a unique
immune response to L. chagasi/infantum is initiated early during the
initial interactions between the first immune system cells that
encounter the parasite. These include macrophages and T-cells,
elements of the innate and adaptive immune systems, respectively.
To that end, we used microarrays to examine early gene
expression patterns in purified Leishmania-naı ¨ve human T cells
during their first encounter with infected human macrophages.
The data suggested that macrophages exhibit a quiescent
phenotype 24 hrs after infection with Leishmania, but Leishman-
ia-naı ¨ve T cells respond to infected MDMs primarily with an
inflammatory or a type 1 immune cytokine response. These in vitro
data suggest that the initial microenvironment created at the site of
Leishmania infection may be conducive to development of a type
1 adaptive immune response.
Immune responses during symptomatic VL are dominated by
suppression of antigen-specific IFN-c responses[3] and patients
have high levels of the suppressive cytokines IL-10 and TGF-b in
their serum with a negative Montenegro reactions.[8–10,13,19]
Whether this immunosuppression initiates early in the process of
macrophage:T cell interactions is not fully known.
Several studies have previously profiled transcriptional respons-
es of phagocytic cells to Leishmania infection. Buates and
Matlashewski[14] showed that in L. donovani infected BALB/c
macrophages, ,40% of the examined genes in a modified array
are down-regulated 4 hours after infection. Rodriguez et al.[39]
reported that murine macrophages exhibited a novel non-classical,
non-alternative activation profile at early time points after L.
chagasi infection. More recently, Chaussabel et al.[40] used
microarrays to compare gene expression in human macrophages
or dendritic cells infected for 16 hours with a variety of parasitic
and bacterial pathogens including L. major and L. donovani. These
authors showed that Leishmania infection invokes the expression
of a novel set of genes that is Leishmania species-specific. Notably,
L. major-infected macrophages down-regulated IFN-c induced
genes yet overall induce a stronger inflammatory profile than does
L. donovani. Both Leishmania species induce IL6 gene expression.
Prior studies of PBMCs incubated with species of Leishmania
causing cutaneous leishmaniasis, called in vitro priming systems,
demonstrated the prominent production of type 1 cytokines (IL-12
and IFN-c) but lower levels of type 2 cytokines such as IL-5.[41] In
contrast, infection of PBMCs with L. donovani, which causes
visceral leishmaniasis, inhibits the of production of pro-inflamma-
Figure 2. Validation of microarray data with TaqMan RT-PCR of selected differentially expressed genes. RNA was extracted from
human MDM-T cell co-cultures 4 hours after the addition of T-cells to infected or uninfected macrophages (28 total hours of L. chagasi infection). The
relative expression of genes in infected compared to uninfected levels, in two separate donors, was examined using TaqMan RT-PCR. Six genes
identified to be differentially expressed in the primary microarray analysis were selected for validation. Relative expression of infected samplesi s
displayed in reference to a line at y=1, signifying no change. Bars below y=1 signify genes that have decreased expression relative to uninfected
samples. The black arrows at the bottom indicate the relative magnitude and direction of change anticipated from the microarray data.
doi:10.1371/journal.pntd.0000252.g002
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of IFN-c signaling pathways.[43] During the current study, we
pursued a global analysis of gene expression shortly after human
peripheral blood derived macrophages first encounter Leishmania-
naı ¨ve T-cells. Based on previously published work from our
laboratory, promastigotes convert to amastigotes by 24–48 hours
after infection of human macrophages.[44] Furthermore, during
infection of murine macrophages with wild-type L. chagasi, fusion
of developing phagosomes with lysosomes is delayed for 24–
48 hours.[45] At the 28 hour post infection time point examined
in this assay, it is therefore reasonable to assume that most if not all
parasites will have converted to amastigotes and reside within
phagolysosomes.
Examination of genes expressed in the infected-macrophages-
only condition revealed more genes were down-regulated than
were induced. Macrophage activation patterns can be divided into
classical, alternative, and Type II activation. Alternatively
activated macrophages up-regulate IL-1RA, mannose receptor
(MRC1), scavenger receptor (CD36), the low-affinity IgE receptor
(CD23) and exhibit high arginase activity. Type II macrophages
up-regulate sphingosine kinase 1 (SPHK1), LIGHT, TNF-SF14,
FIZZ1 and IL-10, have high NO
. production but remain arginase
low.[32,39,46] Of the above characteristic macrophage activation
transcripts, none were significantly up- or down-regulated after
28 hours of L. chagasi infection. It is possible that some of the above
defining macrophage activation markers would have been up- or
down-regulated if samples had been taken earlier after the
initiation of infection. Nonetheless, the time point chosen for this
study captured macrophages harboring converted intracellular
amastigotes[44] and the MDM alone condition allowed us to
compare background gene expression by infected macrophages
with the macrophage-T cell co-culture condition.
To our surprise, and in contrast with the quiescent phenotype of
the infected-macrophages, four hours after the addition of
Leishmania-naı ¨ve T cells to infected macrophages, multiple genes
characteristic of a type 1 immune cytokine response were up-
regulated. Highlights of up-regulated transcripts included IFN-c,
STAT-1, IL-1a, IL-1b, TNF-a and IL-6. Further bioinformatics
analysis using GSEA confirmed the fact that genes and pathways
initiated by pro-inflammatory cytokines and chemokines were up-
regulated. Additionally, using GSEA we also observed enrichment
of the TGF-b pathway; a cytokine that is suppressive of both Th1-
type and Th2-type immune responses.[37,38] Although we cannot
discern exactly which cell type (MDM or T cell) contributed most
highly to the above transcripts, comparison with the MDM alone
conditions suggests that at least some of the cytokines such as IFN-
c may have been derived from T-cells. It should be emphasized
that other cell types such as dendritic cells and NK cells should
have been largely excluded from the co-culture through the
positive selection on the purification column.
Direct measurements of mRNA and protein levels in the co-
cultured infected macrophages and T cells showed that the steady
state abundance of both the mRNA and protein of IFN-c and IL-6
accumulated significantly by 3d in the co-cultures (Figure 3).
Although IL10 mRNA did not appreciably increase at 3d of
infection, we observed a significant increase in levels of IL-10 in
Figure 3. RT-PCR and cytokine assays of IFN-c, IL-6 and IL-10 in MDM-T-cell co-cultures. MDMs were infected with L. chagasi for 24 hours,
and autologous Leishmania-naı ¨ve T-cells were added for the indicated times. (A) Gene expression was examined comparing RNA harvested at the
same time point from infected versus uninfected co-cultures. All mRNA levels were normalized to GAPDH. (B) Supernatants were collected after the
indicated times of co-culture from uninfected (2) versus infected (+) MDM-T cell co-cultures. Cytokine concentrations were measured using Lincoplex
(Millipore) cytokine beads. Standard curves were generated using standards provided by the company. Data for relative mRNA levels or cytokine
concentrations represent the mean6SEM of three independent infection experiments from different human donors. *=p,0.05. Statistical analysis
was performed using (A) 1-way ANOVA and Tukey’s Multiple Comparison Test or a (B) 2-way ANOVA test, respectively.
doi:10.1371/journal.pntd.0000252.g003
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infection-induced accumulation of IL-6 and IFN-c would be
predicted by their respective mRNA abundance, whereas the
accumulation of IL-10 was unexpected. This finding could reflect
that we missed a transient peak of IL-10 mRNA during MDM
infection. Nonetheless since the IL-10 pathway was not enriched
using GSEA, it is reasonable to hypothesize that the accumulation
of IL-10 could be a secondary, modifying response to the increase
in IFN-c and IL-6 rather than a primary response to Leishmania
infected macrophages. The same scenario could be hypothesized
for TGF-b.
The present data suggest that the initial interactions of L. chagasi-
infected macrophages with the adaptive immune system results
primarily in up-regulation of type 1 immune cytokine responses.
There was little evidence for type 2 activation, as IL-4 was only up-
regulated slightly less than two-fold in the primary microarray co-
culture data and characteristic type 2 chemokine receptors such as
CCR3[47] were, in fact, down-regulated. It remains to be
determined at what point L. chagasi parasites begin to tip the
balance of immunity away from a curative type 1, IFN-c response
to cause symptomatic disease.
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